Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 125

Sort by

Sort Order Select

Journal Articles

Integrin αvβ8-mediated TGF-β1 activation regulates sustained response in immune thrombocytopenia after TPO-RA withdrawal

Heng Mei, Min Xu, Jinhui jin Shu, Lu Tang, Qinying Xie, Lili Luo, Qiuzhe Wei, Huiwen Jiang, Zhangyin Ming, Yu Hu

Blood blood.2025029769.

https://doi.org/10.1182/blood.2025029769

Published: 2025

Includes: Supplemental data

Journal Articles

Single-center experience with mitoxantrone hydrochloride liposome-based therapy for patients with myeloid sarcoma

Wenjuan He, Qiuling Wu, Li Weiming, Chun Zhang, Mei Hong, Jianming Yu, Jing Zou, Yu Hu

Blood (2025) 146 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2025-3406

Published: 2025

Journal Articles

Effectiveness and safety of axicabtagene ciloleucel (Axi-cel) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma: Age subgroup analysis of real-world study

Zi-Xun Yan, Wenbin Qian, Ying Lu, Keshu Zhou, Dongmei Ji, Yuhua Li, Dehui Zou, Lanfang Li, Lei Zhang, Ping Li, Hongmei Jing, Chunyan Ji, Ting Niu, Fei Li, Xiaojian Zhu, Jinghua Zhao, Yu Hu, Depei Wu, Wei Li Zhao

Blood (2025) 146 (Supplement 1): 7230.

https://doi.org/10.1182/blood-2025-7230

Published: 2025

Journal Articles

A retrospective study on orelabrutinib combined with anti-CD20 monoclonal antibody regimen in treating mucosa-associated lymphoid tissue lymphoma.

Hongyong Zhang, Zhipeng Cheng, Yingying Wu, Chunyan Sun, Danying Liao, Guohui Cui, Linghui Xia, Yu Hu, Heng Mei, Jun Fang

Blood (2025) 146 (Supplement 1): 7130.

https://doi.org/10.1182/blood-2025-7130

Published: 2025

Journal Articles

BCMA-targeted CAR T cells for multi-refractory primary immune thrombocytopenia: A pilot study

Jinhui Shu, Min Xu, Wei Xie, Lin Liu, Qiuzhe Wei, Hongjian Li, Jishuai Zhang, Yu Hu, Heng Mei

Blood (2025) 146 (Supplement 1): 1267.

https://doi.org/10.1182/blood-2025-1267

Published: 2025

Journal Articles

Reduction in corticosteroid use with rilzabrutinib and sustained response in adults with persistent/chronic immune thrombocytopenia in the long-term extension period of the Phase 3 LUNA3 study

David Kuter, Lei Zhang, Waleed Ghanima, Yoshitaka Miyakawa, Yu Hu, David Gomez-Almaguer, Matias Cordoba, Marek Wardecki, Larissa Mege, Meredith Foster, Ahmed Daak, Howard Liebman

Blood (2025) 146 (Supplement 1): 1260.

https://doi.org/10.1182/blood-2025-1260

Published: 2025

Journal Articles

Quality of life in multiple myeloma: A scoping review

Aoshuang Xu, Han Yan, Qun Li, Sha Liu, Chunyan Sun, Yu Hu

Blood (2025) 146 (Supplement 1): 2807.

https://doi.org/10.1182/blood-2025-2807

Published: 2025

Journal Articles

Humanized anti-CD25 monoclonal antibody for previously treated hemophagocytic lymphohistiocytosis in adults: A prospective, open-label clinical trial

Tingting Liu, Haiming Kou, Yu Hu, Chunrui Li, Liang Tang

Blood (2025) 146 (Supplement 1): 1226.

https://doi.org/10.1182/blood-2025-1226

Published: 2025

Journal Articles

Single-cell RNA sequencing reveals cellular heterogeneity and molecular features of extramedullary-involved multiple myeloma

yajun Wang, quande Lin, jiangxue Hou, xu Ji, Chunyan Sun, Yu Hu

Blood (2025) 146 (Supplement 1): 7472.

https://doi.org/10.1182/blood-2025-7472

Published: 2025

Journal Articles

Dynamic monitoring of circulating plasma cells in multiple myeloma: A Prospective multicenter study in China

Qun Li, Xiaojing Yan, Jian-Qing Mi, Aijun Liao, Bingzong Li, Hui-Han Wang, Huili Cai, Yafei Wang, Li Cai, Yu Hu, Chunyan Sun

Blood (2025) 146 (Supplement 1): 3984.

https://doi.org/10.1182/blood-2025-3984

Published: 2025

Journal Articles

DDX3X facilitates adaption to proteotoxic stress by regulating the translation of MAPKAPK2 and the stability of TMCO1 via stress granules in multiple myeloma

Fengjuan Fan, Shijun Jiang, Enqi Ni, Zhengyufan Wang, Yajun Wang, Liping Zuo, Chi Ma, Sonia Vallet, Aoshuang Xu, Jian Xu, Klaus Podar, Chunyan Sun, Yu Hu

Blood (2025) 146 (Supplement 1): 3944.

https://doi.org/10.1182/blood-2025-3944

Published: 2025

Journal Articles

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Taiyuan Zhang, Yingying Wu, Zhipeng Cheng, Ao Zhang, Lin Liu, Lu Zhang, Danying Liao, Wei Xie, Fang Liu, Guohui Cui, Yu Hu, Heng Mei, Jun Fang

Blood (2025) 146 (Supplement 1): 7207.

https://doi.org/10.1182/blood-2025-7207

Published: 2025

Journal Articles

Automated subtype classification of acute leukemia from bone marrow smears using a cross-platform deep learning model

Guangqi Wang, Hualong Zhao, Enmin Song, Hong Liu, Wanxin Chen, Jian Li, Chunyan Sun, Zhangbo Chu, Yu Hu

Blood (2025) 146 (Supplement 1): 6128.

https://doi.org/10.1182/blood-2025-6128

Published: 2025

Journal Articles

Hetrombopag for patients with persistent primary immune thrombocytopenia: A post-hoc analysis of a multicenter, randomized phase Ⅲ Trial

Blood (2025) 146 (Supplement 1): 4812.

https://doi.org/10.1182/blood-2025-4812

Published: 2025

Journal Articles

Olverembatinib (HQP1351) demonstrates efficacy vs. best available therapy (BAT) in patients (pts) with tyrosine kinase inhibitor (TKI)-resistant chronic-Phase chronic myeloid leukemia (CML-CP) in a registrational randomized Phase 2 trial: Up to 4-year follow-up including patients without T315I mutations

Blood (2025) 146 (Supplement 1): 3788.

https://doi.org/10.1182/blood-2025-3788

Published: 2025

Journal Articles

Updated efficacy and safety of olverembatinib (HQP1351) as second-line therapy in patients (pts) with chronic Phase-chronic myeloid leukemia (CP-CML)

Li Weiming, Yanli Zhang, Huangling Zhu, Yunfan Yang, Na Xu, Bingcheng LIU, Fang Cheng, Zi Chen, Wei Chu, Yifan Zhai, Yu Hu

Blood (2025) 146 (Supplement 1): 3782.

https://doi.org/10.1182/blood-2025-3782

Published: 2025

Journal Articles

Phase 3 ESLIM-01 study: Final analysis of efficacy and safety of long-term treatment with sovleplenib in adults with chronic primary immune thrombocytopenia

Blood (2025) 146 (Supplement 1): 843.

https://doi.org/10.1182/blood-2025-843

Published: 2025

Journal Articles

Quantitative morphological parameters of bone marrow plasma cells are predictive of outcomes in plasma cell dyscrasias

Guangqi Wang, Hualong Zhao, Enmin Song, Hong Liu, Wanxin Chen, Jian Li, Zhangbo Chu, Chunyan Sun, Yu Hu

Blood (2025) 146 (Supplement 1): 5789.

https://doi.org/10.1182/blood-2025-5789

Published: 2025

Journal Articles

Real-world safety and effectiveness of hetrombopag in patients with primary immune thrombocytopenia

Heng Mei, Fengkui Zhang, Yu Hu

Blood (2025) 146 (Supplement 1): 3034.

https://doi.org/10.1182/blood-2025-3034

Published: 2025

Journal Articles

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

Blood (2025) 145 (24): 2914–2926.

https://doi.org/10.1182/blood.2024027336

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Integrin αvβ8-mediated TGF-β1 activation regulates sustained response in immune thrombocytopenia after TPO-RA withdrawal

Single-center experience with mitoxantrone hydrochloride liposome-based therapy for patients with myeloid sarcoma

Effectiveness and safety of axicabtagene ciloleucel (Axi-cel) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma: Age subgroup analysis of real-world study

A retrospective study on orelabrutinib combined with anti-CD20 monoclonal antibody regimen in treating mucosa-associated lymphoid tissue lymphoma.

BCMA-targeted CAR T cells for multi-refractory primary immune thrombocytopenia: A pilot study

Reduction in corticosteroid use with rilzabrutinib and sustained response in adults with persistent/chronic immune thrombocytopenia in the long-term extension period of the Phase 3 LUNA3 study

Quality of life in multiple myeloma: A scoping review

Humanized anti-CD25 monoclonal antibody for previously treated hemophagocytic lymphohistiocytosis in adults: A prospective, open-label clinical trial

Single-cell RNA sequencing reveals cellular heterogeneity and molecular features of extramedullary-involved multiple myeloma

Dynamic monitoring of circulating plasma cells in multiple myeloma: A Prospective multicenter study in China

DDX3X facilitates adaption to proteotoxic stress by regulating the translation of MAPKAPK2 and the stability of TMCO1 via stress granules in multiple myeloma

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Automated subtype classification of acute leukemia from bone marrow smears using a cross-platform deep learning model

Hetrombopag for patients with persistent primary immune thrombocytopenia: A post-hoc analysis of a multicenter, randomized phase Ⅲ Trial

Updated efficacy and safety of olverembatinib (HQP1351) as second-line therapy in patients (pts) with chronic Phase-chronic myeloid leukemia (CP-CML)

Phase 3 ESLIM-01 study: Final analysis of efficacy and safety of long-term treatment with sovleplenib in adults with chronic primary immune thrombocytopenia

Quantitative morphological parameters of bone marrow plasma cells are predictive of outcomes in plasma cell dyscrasias

Real-world safety and effectiveness of hetrombopag in patients with primary immune thrombocytopenia

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only